Verified Supplement Data Evidence-based supplement comparisons

Supplements for Anxiety and Depression (2026): Evidence-Ranked Protocol

By Verified Supplement Data · Published · Methodology · About Us

Evidence-ranked supplement protocol for anxiety and depression:

1. Magnesium glycinate 400mg at bedtime — meta-analysis of 7 RCTs shows moderate-to-large anxiolytic effect. ~$0.24/day.

2. Omega-3 EPA-dominant 2-3g/day — CANMAT Grade A recommendation as adjunct depression treatment. ~$0.45/day.

3. Ashwagandha KSM-66 600mg/day — cortisol reduced 28% in RCT (Chandrasekhar 2012). ~$0.22/day.

4. Vitamin D3 2,000-5,000 IU/day — meta-analysis: each 1,000 IU slightly reduced depressive symptoms. ~$0.07/day.

5. SAMe 400-1,600mg/day — CANMAT Grade A for unipolar depression adjunct. ~$0.57/day. WARNING: Do NOT combine with SSRIs/SNRIs without medical supervision.

Total protocol cost: $1.55/day (~$$47/month).

The 30-Second Version

Start with magnesium glycinate (400mg at bedtime) + omega-3 EPA (2g with breakfast). These two have the strongest evidence and cost under $1.00/day combined. Add ashwagandha and vitamin D when ready.

Buy the Full Anxiety Protocol on Amazon — ~$47/month

Adds magnesium, omega-3, ashwagandha, vitamin D, and SAMe to your Amazon cart

Evidence-Ranked Protocol

Supplements for anxiety and depression: evidence level, dose, and daily cost
SupplementDoseEvidence LevelKey FindingCost/DayBuy
Magnesium Glycinate 400mg at bedtime Strongest Evidence 7 RCTs: moderate-to-large anxiolytic effect; GAD-7 scores -4.5 points (P<0.001) in single RCT (PMID: 28654669) $0.24 Buy
Omega-3 (EPA-dominant) 2-3g EPA+DHA/day Strongest Evidence CANMAT Grade A for adjunct depression treatment; EPA-dominant formulas most effective $0.45 Buy
Ashwagandha KSM-66 600mg/day (300mg 2x) Good Evidence Cortisol -27.9% vs -7.9% placebo in 60-day RCT (PMID: 23439798) $0.22 Buy
Vitamin D3 2,000-5,000 IU/day Strongest Evidence Meta-analysis of RCTs: each 1,000 IU slightly reduced depressive symptoms; most benefit when deficient $0.07 Buy
SAMe 400-1,600mg/day Strongest Evidence CANMAT Grade A for unipolar depression adjunct; comparable to tricyclics in some trials $0.57 Buy
TOTAL PROTOCOL COST $1.55

Evidence grading: Strongest Evidence = meta-analysis of multiple RCTs. Good Evidence = multiple randomized controlled trials. Preliminary Evidence = observational or limited data.

Clinical Evidence by Supplement

1. Magnesium Glycinate 400mg — Strongest Starting Point

Magnesium modulates GABA receptors, blocks excessive NMDA glutamate signaling, and regulates the HPA stress axis. About 50% of Americans consume below the RDA (PMID: 22364157).

  • Tarleton 2017 RCT: 126 adults with mild-to-moderate depression took 248mg Mg/day for 6 weeks. GAD-7 anxiety scores dropped 4.5 points (P<0.001). PHQ-9 depression scores also improved significantly. Effects appeared within 2 weeks and were consistent regardless of antidepressant use (PMID: 28654669).
  • Boyle 2017 systematic review: 18 studies found evidence "suggestive of a beneficial effect" in anxiety-vulnerable populations (PMID: 28445426).
  • Noah 2021 RCT: 300mg Mg + 30mg B6 reduced anxiety and depression in stressed adults (PMID: 33864354).

Why glycinate: Higher bioavailability than oxide or citrate (PMID: 11794633), and the glycine component has independent calming and sleep-promoting effects (PMID: 22293292).

2. Omega-3 EPA-Dominant 2-3g/day — Grade A for Depression

EPA (eicosapentaenoic acid) is the anti-inflammatory omega-3 most relevant to mood disorders. Multiple meta-analyses have demonstrated benefit, and CANMAT (Canadian Network for Mood and Anxiety Treatments) assigns Grade A evidence for omega-3 as an adjunct treatment for major depressive disorder.

  • Liao et al. 2019 meta-analysis: 26 RCTs (n=2,160) found EPA-dominant formulas (≥60% EPA) significantly reduced depressive symptoms compared to placebo. Formulas with ≥1g EPA showed the most robust effects (Liao et al., Translational Psychiatry, 2019).
  • CANMAT 2016 Guidelines: Recommend omega-3 with ≥1g EPA as first-line adjunctive treatment for MDD (Ravindran et al., Canadian Journal of Psychiatry, 2016).

Key detail: EPA-dominant formulas outperform DHA-dominant ones for depression. Look for products providing at least 1g EPA per serving. The mechanism involves reducing neuroinflammation and modulating serotonin receptor sensitivity.

3. Ashwagandha KSM-66 600mg/day — Cortisol Reduction

Ashwagandha is the most studied adaptogen for stress-related anxiety. It modulates the HPA axis, reducing cortisol — the primary stress hormone that drives both anxiety and depression when chronically elevated.

  • Chandrasekhar 2012 RCT: 64 adults with chronic stress took 300mg KSM-66 twice daily for 60 days. Serum cortisol decreased 27.9% vs. 7.9% in placebo (p<0.0001). All stress-assessment scores improved significantly (PMID: 23439798).
  • Pratte 2014 systematic review: 5 clinical trials found ashwagandha significantly reduced anxiety on standardized measures (PMID: 31517876).

Onset: 4-8 weeks of consistent use. Cycle 8 weeks on, 2 weeks off. Not for use during pregnancy, with autoimmune conditions, or thyroid disorders.

4. Vitamin D3 2,000-5,000 IU/day — Correct Deficiency First

Vitamin D receptors are present throughout the brain, including regions involved in mood regulation. Deficiency (<20 ng/mL) is extremely common, especially during winter and in northern latitudes.

  • Cheng et al. 2020 meta-analysis: Analysis of RCTs found vitamin D supplementation had a small but statistically significant effect on reducing depressive symptoms, with each additional 1,000 IU providing incremental benefit (Cheng et al., Journal of Affective Disorders, 2020).
  • The effect is most meaningful in people who are actually deficient. Get your 25(OH)D tested before high-dose supplementation.

Optimal range for mood: 40-60 ng/mL. Take with a fat-containing meal to maximize absorption (vitamin D is fat-soluble).

5. SAMe 400-1,600mg/day — Powerful but Use with Caution

S-Adenosyl-L-Methionine (SAMe) is a naturally occurring molecule involved in methylation, neurotransmitter synthesis, and membrane phospholipid production. It has robust evidence for depression — CANMAT assigns Grade A for adjunctive treatment of unipolar depression.

  • De Berardis et al. 2016 review: SAMe has been shown to be more effective than placebo and comparable to tricyclic antidepressants in some trials. It may also accelerate antidepressant response (De Berardis et al., CNS & Neurological Disorders Drug Targets, 2016).
  • CANMAT guidelines list SAMe as a first-line adjunctive treatment for MDD that has not responded to initial antidepressant therapy.

Dosing: Start at 400mg/day on an empty stomach. Increase by 200mg every 1-2 weeks if tolerated, up to 1,600mg/day. SAMe can cause insomnia and GI upset at higher doses. Take in the morning to minimize sleep disruption.

Medication Interactions

Supplement-medication interactions for anxiety and depression protocols
CombinationRisk LevelDetails
SSRIs + Omega-3 SAFE Explicitly recommended as adjunct by CANMAT clinical guidelines. No negative interaction. May enhance antidepressant effect.
SSRIs + SAMe DANGER Serotonin syndrome risk. SAMe increases serotonin synthesis. Combined with SSRIs, serotonin levels can reach dangerous levels. Do NOT combine without medical supervision.
Benzodiazepines + Magnesium CAUTION Magnesium enhances GABA activity through the same system benzodiazepines target. May increase sedation. Start magnesium at a lower dose (200mg) and monitor for excessive drowsiness.
SSRIs + Magnesium SAFE No interaction. The Tarleton 2017 RCT found magnesium effective regardless of concurrent antidepressant use.
SSRIs + Vitamin D SAFE No interaction. Vitamin D works through entirely different pathways (VDR gene expression, not neurotransmitter modulation).
SSRIs + Ashwagandha CAUTION Generally considered safe, but ashwagandha may have mild serotonergic effects. Consult your prescriber. Start at 300mg/day.

General rule: If you are taking any psychiatric medication, share this protocol with your prescriber before starting supplements. The items marked "SAFE" have clinical trial evidence supporting co-administration, but individual responses vary.

Daily Timing Protocol

When to take each supplement in the anxiety-depression protocol
TimeSupplementDoseWith Food?Notes
Morning SAMe 400-800mg Empty stomach Take 30 min before breakfast. Can cause insomnia if taken later in the day.
With breakfast/lunch Omega-3 (EPA-dominant) 2-3g EPA+DHA Yes (with fat) Split dose OK: 1-1.5g with breakfast, 1-1.5g with lunch. Reduces fish burps.
With breakfast/lunch Vitamin D3 2,000-5,000 IU Yes (with fat) Fat-soluble — take with meal containing fat for absorption. Morning is fine.
Evening Ashwagandha KSM-66 300mg (2nd dose) With dinner If taking 600mg total: 300mg morning + 300mg evening. Evening dose supports sleep.
Bedtime Magnesium Glycinate 400mg Light snack OK 30-60 min before bed. Mild sedation + glycine supports sleep quality.

Monthly Cost Breakdown

Full protocol monthly cost using best-value products
SupplementProductCost/DayCost/Month
Magnesium Glycinate Vitamin Shoppe Magnesium Glycinate 400mg $0.24 $7
Omega-3 EPA Sports Research Triple Strength Omega-3 (1250mg) $0.45 $14
Ashwagandha KSM-66 Nootropics Depot KSM-66 Ashwagandha (300mg, 90ct) $0.22 $7
Vitamin D3 Nature Made Vitamin D3 2000 IU $0.07 $2
SAMe Doctor's Best SAMe 400mg $0.57 $17
TOTAL $1.55 ~$$47

What NOT to Waste Money On

  • St. John's Wort — Has some evidence for mild depression, but dangerous interactions with SSRIs, birth control, blood thinners, and many other medications. The interaction risk outweighs the benefit for most people already on medication.
  • "Mood support" proprietary blends — Underdose every ingredient. Get each supplement at the clinically studied dose individually.
  • 5-HTP without medical guidance — Direct serotonin precursor. Same serotonin syndrome risk as SAMe when combined with SSRIs. Not recommended without prescriber involvement.
  • Magnesium oxide for anxiety — ~4% bioavailability. Most passes through unused. Glycinate is the form studied for mood.

Get Protocol Updates

Join our list for evidence updates, new condition protocols, and supplement price alerts.

Frequently Asked Questions

What is the best supplement for anxiety and depression?

Magnesium glycinate is the best starting point due to its strong risk-benefit profile. A meta-analysis of 7 RCTs found moderate-to-large anxiolytic effects, and the Tarleton 2017 RCT showed a 4.5-point GAD-7 reduction within 2 weeks (PMID: 28654669). It costs ~$0.24/day and is safe with most medications. For depression specifically, omega-3 EPA at 2-3g/day has CANMAT Grade A evidence as an adjunct treatment.

Can you take supplements with antidepressants?

Most supplements in this protocol are safe alongside SSRIs/SNRIs. Omega-3 is explicitly supported as an adjunct by CANMAT guidelines. Magnesium and vitamin D have no interaction with antidepressants. The exception is SAMe — it should NOT be combined with SSRIs/SNRIs due to serotonin syndrome risk. Always consult your prescriber before combining supplements with psychiatric medication.

How much magnesium should I take for anxiety?

Clinical trials used 248-400mg of elemental magnesium per day as the glycinate form. Effects appeared within 2 weeks (PMID: 28654669). Start at 200mg and increase to 400mg if well tolerated. Take at bedtime for the dual benefit of anxiety relief and sleep support. The glycine component has independent calming effects (PMID: 22293292).

Does vitamin D help with depression?

A meta-analysis of RCTs found that vitamin D supplementation slightly reduced depressive symptoms, with each additional 1,000 IU showing incremental benefit. However, the effect is most meaningful in people who are actually deficient (blood levels below 20 ng/mL). Get your 25(OH)D tested before supplementing at high doses. The optimal range for mood is generally considered 40-60 ng/mL.

Is ashwagandha safe for anxiety?

Ashwagandha KSM-66 has been studied at 300-600mg/day in multiple RCTs with a good safety profile. The Chandrasekhar 2012 RCT found a 27.9% cortisol reduction over 60 days (PMID: 23439798). Contraindications: pregnancy, autoimmune conditions, and thyroid disorders. Cycle 8 weeks on, 2 weeks off. It is not a replacement for psychiatric medication.

Related

Sources

  1. Tarleton EK, et al. "Role of magnesium supplementation in the treatment of depression." PLoS ONE. 2017;12(6):e0180067. PMID: 28654669
  2. Boyle NB, Lawton C, Dye L. "The Effects of Magnesium Supplementation on Subjective Anxiety and Stress." Nutrients. 2017;9(5):429. PMID: 28445426
  3. Noah L, et al. "Effect of magnesium and vitamin B6 supplementation on mental health." Stress Health. 2021;37(5):1010-1023. PMID: 33864354
  4. Rosanoff A, et al. "Suboptimal magnesium status in the United States." Nutr Rev. 2012;70(3):153-164. PMID: 22364157
  5. Firoz M, Graber M. "Bioavailability of US commercial magnesium preparations." Magnes Res. 2001;14(4):257-62. PMID: 11794633
  6. Bannai M, Kawai N. "New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep." J Pharmacol Sci. 2012;118(2):145-148. PMID: 22293292
  7. Chandrasekhar K, Kapoor J, Anishetty S. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root." Indian J Psychol Med. 2012;34(3):255-62. PMID: 23439798
  8. Pratte MA, et al. "An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results for Ashwagandha." J Altern Complement Med. 2014;20(12):901-908. PMID: 31517876
  9. Liao Y, et al. "Efficacy of omega-3 PUFAs in depression: a meta-analysis." Translational Psychiatry. 2019;9:190.
  10. Ravindran AV, et al. "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines: Complementary and Alternative Medicine Treatments." Canadian Journal of Psychiatry. 2016;61(9):576-587.
  11. Cheng YS, et al. "Supplementation of vitamin D for depression: A meta-analysis of randomized controlled trials." Journal of Affective Disorders. 2020;266:647-656.
  12. De Berardis D, et al. "The Role of S-Adenosyl-L-Methionine in Major Depressive Disorder." CNS & Neurological Disorders Drug Targets. 2016;15(1):35-44.